These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9369448

  • 1. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
    Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M.
    Mol Endocrinol; 1997 Nov; 11(12):1806-13. PubMed ID: 9369448
    [Abstract] [Full Text] [Related]

  • 2. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M, Gilbert S, Rosenthal W.
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [Abstract] [Full Text] [Related]

  • 3. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, de Zegher F, Corydon TJ.
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
    [Abstract] [Full Text] [Related]

  • 4. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
    Sadeghi HM, Innamorati G, Birnbaumer M.
    Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
    [Abstract] [Full Text] [Related]

  • 5. Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus.
    Postina R, Ufer E, Pfeiffer R, Knoers NV, Fahrenholz F.
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):31-9. PubMed ID: 11026555
    [Abstract] [Full Text] [Related]

  • 6. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [Abstract] [Full Text] [Related]

  • 7. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
    Armstrong SP, Seeber RM, Ayoub MA, Feldman BJ, Pfleger KD.
    PLoS One; 2013 Aug; 8(6):e65885. PubMed ID: 23762448
    [Abstract] [Full Text] [Related]

  • 8. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
    Inaba S, Hatakeyama H, Taniguchi N, Miyamori I.
    J Clin Endocrinol Metab; 2001 Jan; 86(1):381-5. PubMed ID: 11232028
    [Abstract] [Full Text] [Related]

  • 9. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI, Cho HY, Park HW, Ha IS, Choi Y.
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.
    Erdélyi LS, Balla A, Patócs A, Tóth M, Várnai P, Hunyady L.
    Mol Endocrinol; 2014 May; 28(5):634-43. PubMed ID: 24628417
    [Abstract] [Full Text] [Related]

  • 12. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
    Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, Gitelman SE, Rosenthal SM, von Zastrow M, Bouvier M.
    Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
    [Abstract] [Full Text] [Related]

  • 13. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.
    Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, Cotte N, Déchaux M, Antignac C, Arthus MF, Lonergan M, Turner MS, Balestre MN, Alonso G, Hibert M, Barberis C, Hendy GN, Bichet DG, Jard S.
    J Am Soc Nephrol; 1998 Oct; 9(10):1861-72. PubMed ID: 9773787
    [Abstract] [Full Text] [Related]

  • 14. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
    Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T.
    J Biol Chem; 2012 Jan 13; 287(3):2099-106. PubMed ID: 22144672
    [Abstract] [Full Text] [Related]

  • 15. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
    Miyakoshi M, Kamoi K, Uchida S, Sasaki S.
    Endocr J; 2003 Dec 13; 50(6):809-14. PubMed ID: 14709855
    [Abstract] [Full Text] [Related]

  • 16. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
    Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, Miller WL, Vaisse C.
    Clin Endocrinol (Oxf); 2009 Sep 13; 71(3):388-93. PubMed ID: 19170711
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
    Bockenhauer D, Carpentier E, Rochdi D, van't Hoff W, Breton B, Bernier V, Bouvier M, Bichet DG.
    Nephron Physiol; 2010 Sep 13; 114(1):p1-10. PubMed ID: 19816050
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.
    Makita N, Sato T, Yajima-Shoji Y, Sato J, Manaka K, Eda-Hashimoto M, Ootaki M, Matsumoto N, Nangaku M, Iiri T.
    J Biol Chem; 2016 Oct 21; 291(43):22460-22471. PubMed ID: 27601473
    [Abstract] [Full Text] [Related]

  • 19. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.
    Yokoyama K, Yamauchi A, Izumi M, Itoh T, Ando A, Imai E, Kamada T, Ueda N.
    J Am Soc Nephrol; 1996 Mar 21; 7(3):410-4. PubMed ID: 8704106
    [Abstract] [Full Text] [Related]

  • 20. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W.
    Mol Pharmacol; 1996 Oct 21; 50(4):820-8. PubMed ID: 8863826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.